Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $41.91 Analyst target: $47.58 Upside: 13.53%
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.